Drug Profile
Beta-2-microglobulin
Alternative Names: Beta2mLatest Information Update: 28 Sep 2020
Price :
$50
*
At a glance
- Originator Beta Innov; University Hospital of Montpellier
- Class
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Autoimmune disorders
Most Recent Events
- 28 Sep 2020 No recent reports of development identified for research development in Autoimmune-disorders in France (IV, Injection)
- 10 Aug 2016 Early research in Autoimmune disorders in France (IV)